tradingkey.logo

tradingkey.logo
怜玢


SBC Medical Group Holdings Inc

SBC
りォッチリストに远加
5.370USD
+0.090+1.70%
終倀 10-26 16:00ET
552.30M時䟡総額
13.49盎近12ヶ月PER

SBC Medical Group Holdings Incに぀いお 䌁業名

SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

SBC Medical Group Holdings Inc プロフィヌル


䌁業コヌドSBC
䌚瀟名SBC Medical Group Holdings Inc
䞊堎日Sep 26, 2022
最高経営責任者「CEO」Aikawa (Yoshiyuki)
埓業員数863
蚌刞皮類Ordinary Share
決算期末Sep 26
本瀟所圚地200 Spectrum Center Dr.
郜垂IRVINE
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号92618
電話番号19495930250
りェブサむトhttps://ir.sbc-holdings.com/
䌁業コヌドSBC
䞊堎日Sep 26, 2022
最高経営責任者「CEO」Aikawa (Yoshiyuki)

SBC Medical Group Holdings Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Yoshiyuki Aikawa
Dr. Yoshiyuki Aikawa
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
83.84M
--
Dr. Yoshiyuki Aikawa
Dr. Yoshiyuki Aikawa
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
83.84M
--
Mr. Yuya Yoshida
Mr. Yuya Yoshida
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
--
--
Mr. Ken Edahiro
Mr. Ken Edahiro
Independent Director
Independent Director
--
--
Mr. Fumitoshi Fujiwara
Mr. Fumitoshi Fujiwara
Independent Director
Independent Director
--
--
Ms. Miki (Shimizu) Yamazaki
Ms. Miki (Shimizu) Yamazaki
Chief Strategy Officer
Chief Strategy Officer
--
--
Dr. Mike Sayama, Ph.D.
Dr. Mike Sayama, Ph.D.
Independent Director
Independent Director
--
--
Mr. Yuya Yoshida
Mr. Yuya Yoshida
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
--
--
Mr. Akira Komatsu
Mr. Akira Komatsu
Secretary
Secretary
--
--
Mr. Ken Edahiro
Mr. Ken Edahiro
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Yoshiyuki Aikawa
Dr. Yoshiyuki Aikawa
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
83.84M
--
Dr. Yoshiyuki Aikawa
Dr. Yoshiyuki Aikawa
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
83.84M
--
Mr. Yuya Yoshida
Mr. Yuya Yoshida
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
--
--
Mr. Ken Edahiro
Mr. Ken Edahiro
Independent Director
Independent Director
--
--
Mr. Fumitoshi Fujiwara
Mr. Fumitoshi Fujiwara
Independent Director
Independent Director
--
--
Ms. Miki (Shimizu) Yamazaki
Ms. Miki (Shimizu) Yamazaki
Chief Strategy Officer
Chief Strategy Officer
--
--

よくある質問

SBC Medical Group Holdings Incの䞊䜍5名の株䞻は誰ですか


SBC Medical Group Holdings Incの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Yoshiyuki Aikawa

SBC Medical Group Holdings IncSBCの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、SBC Medical Group Holdings Incの株匏を保有しおいる機関は90瀟あり、保有株匏の総垂堎䟡倀は玄1.60Mで、党䜓の1.56%を占めおいたす。2025Q4ず比范しお、機関の持ち株は465540.00増加しおいたす。

SBC Medical Group Holdings Incの最倧の収益源は䜕ですか


2026Q1においお、Procurement services郚門がSBC Medical Group Holdings Incにずっお最倧の収益を生み出しおおり、その金額は13.40Mで、党収益の27.24%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。